Z Pan, K Wang, X Wang, Z Jia,
Y Yang, Y Duan… - Molecular cancer, 2022 - Springer
Background The use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-
TKIs) brings remarkable benefits for the survival of patients with advanced NSCLC harboring …